Development of small hepatocellular carcinoma 80 months after clearance of hepatitis C virus with interferon therapy

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 9, 2000, Pages 1029-1032

  Yamada, M ^a   Ichikawa, M ^a   Matsubara, A ^a   Ishiguro, Y ^a   Yokoi, S ^a  

^a ANJO KOSEI HOSPITAL   (Japan)

Author keywords

Chronic hepatitis C; Complete response; Hepatitis C virus; Hepatocellular carcinoma; Interferon therapy

Indexed keywords

ALPHA FETOPROTEIN; RECOMBINANT ALPHA2A INTERFERON; VIRUS RNA; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ADULT; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOTHERAPY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS HEPATITIS;

EID: 0033827371     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012090-00012     Document Type: Article

References (18)

1. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma
2. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
3. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
4. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis
5. Recombinant interferon alfa therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial
6. Serum hyaluronic acid reflects the effect of interferon treatment on hepatic fibrosis in patients with chronic hepatitis C
7. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C
8. Hepatocellular proliferation and development of hepatocellular carcinoma a case-control study in chronic hepatitis C
9. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease
10. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
11. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C
12. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C
13. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy
14. Case of small hepatocellular carcinoma in the caudate lobe detected after interferon caused disappearance of hepatitis C virus
15. Development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-α
16. Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy
17. Occurrence of hepatocellular carcinoma 45 years after successful treatment with virus clearance for chronic hepatitis C
18. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis: A study in 22 patients